Biomarkers of clinical benefit for anti-epidermal growth factor receptor agents in patients with non-small-cell lung cancer

Non-small-cell lung cancer (NSCLC) remains by far the major cause of cancer-related death in the Western world in both men and women. The majority of patients will be diagnosed with metastatic disease, and chemotherapy doublets remain the cornerstone of treatment for these patients. However, chemoth...

Descripció completa

Dades bibliogràfiques
Autors principals: Pallis, A G, Fennell, D A, Szutowicz, E, Leighl, N B, Greillier, L, Dziadziuszko, R
Format: Online Article Text
Idioma:English
Publicat: Nature Publishing Group 2011
Matèries:
Minireview
Accés en línia:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3137421/
https://www.ncbi.nlm.nih.gov/pubmed/21654681
http://dx.doi.org/10.1038/bjc.2011.207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3137421/
https://www.ncbi.nlm.nih.gov/pubmed/21654681
http://dx.doi.org/10.1038/bjc.2011.207

Ítems similars